Table 5.
Numbers of parent-reported adverse events during week 1
Placebo group (n=170) | Oral steroid group (n=179) | ||
---|---|---|---|
No problems reported | 148 (87%) | 154 (86%) | |
Children reported with at least one problem | 22 (13%) | 25 (14%) | |
Total number of problems | 24 | 27 | |
Respiratory tract infection | |||
Phlegmy cough, cold, sneezing, temperature, nosebleed, conjunctivitis, itchy eyes, or generally unwell | 2 | 7 | |
Headache | 3 | 4 | |
Parotitis | 1 | 0 | |
Ear pain on touch or earache | 1 | 1 | |
Rash, pox, or scarlet fever | 2 | 0 | |
Flushed cheeks | 0 | 1 | |
Digestion | |||
Increased appetite | 4 | 3 | |
Low appetite | 2 | 0 | |
Diarrhoea | 2 | 2 | |
Constipation | 1 | 1 | |
Nausea | 0 | 1 | |
Behaviour | |||
Hyperactive | 1 | 3 | |
Tired | 1 | 1 | |
Frustration | 1 | 0 | |
Change in behaviour | 0 | 2 | |
Parent states child not hearing | 1 | 0 | |
Sleep walking | 0 | 1 | |
Other | |||
Finger infection | 1 | 0 | |
Knee pain | 1 | 0 |